HIV drug stabilizes disease progression in metastatic colorectal cancer: Using reverse transcriptase inhibitors raises the possibility of a new therapeutic strategy in cancer. - Science Daily

Many cancers exhibit high levels of the reverse transcriptase enzyme. Single-agent lamivudine, a reverse transcriptase inhibitor, stopped disease progression in over 25% of patients with fourth-line refractory metastatic colorectal cancer. These results provi…

New clinical research shows that lamivudine, a reverse transcriptase inhibitor widely used in HIV therapy, stopped disease progression in 25% of patients with fourth-line metastatic colorectal cancer… [+3837 chars]

full article...